weight loss drugs

News

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk.

Patients

It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.

Market Access

Recent advancements in weight-loss interventions are transforming the healthcare landscape and presenting new M&A opportunities

Market Access

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.

Sales & Marketing

“Medicated weight loss isn’t cheating.” Since I first wrote about the rise of

News

Eli Lilly has used an Oscars ad to urge people not to use unapproved and untested weight-loss medicines in a swipe at the compounding sector.